Stacey Teale
Corporate Officer
Direct Line: 0151 318 9318
Email:
xxxxxxxxxxx.xxxxxxxxxxxx@xxx.xxx
NHS Wirral Clinical Commissioning Group
Date: 1st June 2020
Marriss House
Hamilton Street
Name: Ben Holdsworth
Birkenhead
Email:
xxxxxxxxxxxxxxxxxxxxxxx@xxxxxxxxxxxxxx.xxx
Wirral
Our Ref: ID 1679
CH41 5AL
Tel: 0151 651 0011
Dear Mr Holdsworth,
Re: Freedom of Information Request – Rebate Agreements
Thank you for your request for information made under the Freedom of Information Act 2000,
which was received into this office on the 11th May 2020.
You Asked for:
I would like to request the below information:
• A list of pharmaceutical products/drugs that your Primary Care organisation currently
holds rebate agreements for. I would like to request the product names (brand and
generic when applicable) with start and finish dates.
I fully understand that the financial details of the rebates would be considered commercially
confidential.
Our Response:
Please see the table below:
Drug
Start Date
Current End Date
Seretide
Jan - 18
Mar - 20
Edoxaban
Oct - 17
Dec - 22
Spiolto
Jul - 16
Mar - 21
Airflusal - Fospiro
Aug - 18
Jul - 20
Glucophage SR
Jan - 20
Dec - 22
Firmagon
Sep - 19
Aug - 20
Reletrans
Aug - 18
Jul - 20
Sitagliptin
Jul - 19
Jul - 20
Clenil
May - 19
May - 21
Sereflo
May - 19
May - 21
Long Tec Oxycodone
Jul - 19
Jul - 21
Rivaroxaban
Sep - 19
Dec - 21
Stexerol / Colecalciferol ( Vit D3)
Nov - 19
Open
Xaggitin
Jan - 20
Dec - 21
Aymes
Jan - 20
Dec - 20
Dressings
Nov - 19
Oct - 21
Biquelle
Jan - 20
Dec - 21
Solaraze
Mar - 20
Mar - 22
Balneum
Mar - 20
Mar - 22
We hope this information is useful, however if you require any further information please do not
hesitate to contact a member of the Corporate Affairs Team (contact details at the top of this
letter)
Yours sincerely
Paul Edwards
Director of Primary Care and Corporate Affairs
NHS Wirral Clinical Commissioning Group
Re- Use of Information
Most of the information that we provide in response to Freedom of Information Act 2000 requests will be
subject to copyright protection. In most cases the copyright will be owned by Wirral Clinical
Commissioning Group. The copyright in other information may be owned by another person or
organisation, as indicated on the information itself.
You are free to use any information supplied for your own non-commercial research or private study
purposes. The information may also be used for any other purpose allowed by a limitation or exception in
copyright law, such as news reporting. However, any other type of re-use, for example by publishing the
information in analogue or digital form, including on the internet, will require the permission of the
copyright owner.
For information where the copyright is owned by Wirral Clinical Commissioning Group please e-mail
xxxxxxxxxxx.xxxxxxxxxxxx@xxx.xxx to request a reuse licence.
For information where the copyright is owned by another person or organisation you must apply to the
copyright owner to obtain their permission.